These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16555958)

  • 1. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():29-40. PubMed ID: 16555958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2003; 31(3):353-64. PubMed ID: 15612876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of stakeholder organisations on the proposed new European chemical policy.
    Dandrea J; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():41-68. PubMed ID: 16555959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system.
    Combes R; Barratt M; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():15-27. PubMed ID: 16555957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system.
    Combes R; Gaunt I; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():77-122. PubMed ID: 16555961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRAME and the Royal Commission on Environmental Pollution: common recommendations for assessing risks posed by chemicals under the EU REACH system.
    Combes R; Dandrea J; Balls M
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():69-75. PubMed ID: 16555960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [White Paper of the European Commission--strategy for a new chemicals policy].
    Spielmann H
    ALTEX; 2002; 19 Suppl 1():20-5. PubMed ID: 12096326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the European centre for the validation of alternative methods (ECVAM) in the validation of (Q)SARs.
    Worth AP; Hartung T; Van Leeuwen CJ
    SAR QSAR Environ Res; 2004; 15(5-6):345-58. PubMed ID: 15669694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prospects for using (Q)SARs in a changing political environment--high expectations and a key role for the European Commission's joint research centre.
    Worth AP; Van Leeuwen CJ; Hartung T
    SAR QSAR Environ Res; 2004; 15(5-6):331-43. PubMed ID: 15669693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
    Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
    SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. REACH: next step to a sound chemicals management.
    Van der Wielen A
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S2-6. PubMed ID: 17637708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
    Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.